Cutaneous Tumor: Clinical Trials

8 trials for Cutaneous Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 recruiting, 2 unknown. 3 Not applicable, 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Recruiting 1
Phase 13Completed 1, Recruiting 1, Unknown 1
Phase 21Completed 1

Follow Cutaneous Tumor: new trials by email Literature Review of Cutaneous Tumor trials Research Report on Cutaneous Tumor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
tolododekin alfa, Cemiplimab - Advanced Solid Tumor, Cutaneous Tumor
Phase 1RecruitingAnkyra Therapeutics, Inc972024-01-192026-03-06
Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors
JCXH-211 Injection - Cutaneous Tumor, Malignant Solid Tumor
Phase 1CompletedImmorna Biotherapeutics, Inc.192023-02-242026-03-24
Topical Anaesthesia in Cutaneous Head and Neck Surgery
EMLA, Ethyl chloride, Aqueous cream BP - Pain, Acute, Head and Neck Cancer
Not applicableCompletedUniversity Hospital Waterford1242023-02-202024-02-23
Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors
JCXH-211 - Cutaneous Tumor, Malignant Solid Tumor
Phase 1UnknownImmorna Biotherapeutics, Inc.12022-10-182023-04-04
Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors
DaRT- Diffusing Alpha-emitters Radiation Therapy - Skin Cancer, Cutaneous Tumor
Not applicableRecruitingAlpha Tau Medical LTD.802022-04-012026-06-16
Ex-vivo Examination of Excisions of Skin Tumors by Confocal Optical Coherence Tomography (LC-OCT) With Integrated Dermoscopy and Comparison With Histology (DERMOCTAV)
Confocal optical coherence tomography - OCTAVE - Cutaneous Tumor, Optical Coherence Tomography
UnknownGCS Ramsay Santé pour l'Enseignement et la Recherche1502021-12-162022-04-22
Study of TVEC in Patients With Cutaneous Squamous Cell Cancer
Injection of TVEC into target lesions - week 1-2, Injection of TVEC into target lesions 3wks after 1st injection, Injection of TVEC into target lesions 2wks after 2nd injection - Squamous Cell Carcinoma, Skin Cancer
Phase 2CompletedUniversity of Arizona112018-12-202024-10-09
Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study
Lay Navigation - Breast Cancer, Gynecologic Cancer
Not applicableCompletedStanford University10532017-02-152019-04-08

Narrower conditions

Skin Neoplasms (8)  ·  Carcinoma, Squamous Cell (3)  ·  Carcinoma, Basal Cell (2)  ·  Head and Neck Neoplasms (2)  ·  Neoplasms (2)  ·  Acute Pain (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Eyelid Neoplasms (1)  ·  Gastrointestinal Neoplasms (1)  ·  Keratoacanthoma (1)  ·  Lip Neoplasms (1)  ·  Lymphoma (1)  ·  Melanoma (1)  ·  Neoplasm Metastasis (1)

Broader conditions

Neoplasms by Site (8)  ·  Skin Diseases (8)  ·  Skin and Connective Tissue Diseases (8)  ·  Neoplasms (6)  ·  Neoplasms by Histologic Type (4)  ·  Carcinoma (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Neoplasms, Squamous Cell (3)  ·  Neoplasms, Basal Cell (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Breast Diseases (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)

Interventions

Ethyl Chloride (1)  ·  cemiplimab (1)

Sponsors

Immorna Biotherapeutics, Inc. (2)  ·  Alpha Tau Medical LTD. (1)  ·  Ankyra Therapeutics, Inc (1)  ·  GCS Ramsay Santé pour l'Enseignement et la Recherche (1)  ·  Stanford University (1)  ·  University Hospital Waterford (1)  ·  University of Arizona (1)

Countries

United States (5)  ·  France (2)  ·  Canada (1)  ·  China (1)  ·  Ireland (1)

Top investigators

Clara Curiel, MD (1)  ·  Joseph Elassal, MD, MBA (1)  ·  Steve Asch, MD (1)

Results publications

PMID 31647691, PMID 41022754